Important Safety Information
Oxymetholone is FDA-approved for specific anemia indications. Anabolic steroids have not been shown to enhance athletic ability, and non-medical use for physique or performance enhancement falls outside approved indications.
Long-term use of oxymetholone can cause liver tumors or blood-filled cysts in the liver (peliosis hepatis). Peliosis hepatis can be life-threatening if the cysts rupture. Liver cell tumors, both benign and malignant, have been reported with oxymetholone use.
Important
Non-Medical Use
Non-medical use of oxymetholone falls outside approved indications and carries significant health risks including severe hepatotoxicity, cardiovascular strain, and endocrine suppression. Product strength and laboratory verification do not establish safety for human consumption.
Potential Adverse Effects
Hepatotoxicity: Oxymetholone is a 17-alpha-alkylated steroid associated with cholestatic jaundice, elevated liver enzymes, peliosis hepatis, and liver tumors.
Cardiovascular effects: Oxymetholone can decrease HDL cholesterol and increase LDL cholesterol, potentially accelerating atherosclerosis. Blood pressure elevation and fluid retention are also common.
Estrogenic effects: Despite not aromatizing classically, oxymetholone can cause gynecomastia and water retention through other pathways.
Androgenic effects: Acne, accelerated male-pattern hair loss, and increased body hair growth are possible. In women, virilization signs including voice deepening, hirsutism, and clitoromegaly may occur and can be irreversible.
Endocrine suppression: Oxymetholone suppresses endogenous testosterone production, leading to testicular atrophy, reduced libido, and potential fertility impairment.
Conditions Requiring Medical Evaluation
Oxymetholone is contraindicated in known or suspected carcinoma of the prostate or male breast, carcinoma of the breast in females with hypercalcemia, pregnancy, nephrosis, and severe hepatic dysfunction. Caution is required in patients with a history of cardiovascular disease, liver disease, or risk factors for either.
Monitoring During Therapy
Medically supervised oxymetholone therapy typically involves periodic laboratory assessment. Liver function tests, cholesterol profile, and hemoglobin/hematocrit should be monitored. In children, radiographs of the left wrist every 6 months may be recommended.
Product Care
Storage & Handling
Store at room temperature away from moisture, heat, and light. Keep the product in its original packaging and out of the reach of children.
Further Safety Information